SPIA
RLAY icon

Steward Partners Investment Advisory’s Relay Therapeutics RLAY Stock Holding History

Steward Partners Investment Advisory’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$101K Sell
5,400
-2,700
-33% -$39.2K ﹤0.01% 2580
2026
Q1 		$80.6K Sell
8,100
-800
-9% -$7.16K ﹤0.01% 2504
2025
Q4 		$75.3K Buy
8,900
+800
+10% +$5.71K ﹤0.01% 2450
2025
Q3 		$42.3K Buy
8,100
+2,000
+33% +$7.63K ﹤0.01% 2692
2025
Q2 		$21.1K Hold
6,100
– – ﹤0.01% 2903
2025
Q1 		$16K Sell
6,100
-400
-6% -$1.57K ﹤0.01% 2901
2024
Q4 		$26.8K Buy
6,500
+4,000
+160% +$21.8K ﹤0.01% 2637
2024
Q3 		$17.7K Buy
2,500
+1,500
+150% +$11.2K ﹤0.01% 2711
2024
Q2 		$6.52K Hold
1,000
– – ﹤0.01% 2963
2024
Q1 		$8.3K Hold
1,000
– – ﹤0.01% 2880
2023
Q4 		$11K Hold
1,000
– – ﹤0.01% 2666
2023
Q3 		$8.41K Hold
1,000
– – ﹤0.01% 2658
2023
Q2 		$12.6K Hold
1,000
– – ﹤0.01% 2491
2023
Q1 		$16.5K Hold
1,000
– – ﹤0.01% 2336
2022
Q4 		$14.9K Hold
1,000
– – ﹤0.01% 2381
2022
Q3 		$22K Hold
1,000
– – ﹤0.01% 2194
2022
Q2 		$17K Hold
1,000
– – ﹤0.01% 2300
2022
Q1 		$30K Hold
1,000
– – ﹤0.01% 2180
2021
Q4 		$31K Hold
1,000
– – ﹤0.01% 2125
2021
Q3 		$32K Buy
+1,000
New +$33.7K ﹤0.01% 2102

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Steward Partners Investment Advisory's RLAY Position: Q2 2026 in Review

Steward Partners Investment Advisory reduced its Relay Therapeutics (RLAY) stake by 33% in Q2 2026, selling an estimated $39.2K and leaving 5,400 shares worth $101K. The position accounts for ﹤0.01% of the portfolio, ranked #2580.

Steward Partners Investment Advisory first reported a position in RLAY in Q3 2021 and has held it in 20 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Steward Partners Investment Advisory held 5,400 shares of Relay Therapeutics worth $101K as of Q2 2026.
  • Steward Partners Investment Advisory sold 2,700 Relay Therapeutics shares in Q2 2026, an estimated $39.2K.
  • Relay Therapeutics made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #2580 holding.
  • Steward Partners Investment Advisory first reported a position in Relay Therapeutics in Q3 2021 and has held it in 20 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.